Skip to content

Study · Ex vivo tissue · rat · 1999

7 results

Oxytocin receptor binding in rat and human heart.

Cicutti NJ, Smyth CE, Rosaeg OP, Wilkinson M

The Canadian journal of cardiology1 Nov 1999Cited by 20 (Europe PMC)

PMID10579742 (opens in a new tab)PepBankPUB-10579742

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study7

7 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabEx vivo tissueActivity measurement

    In rat left ventricle tissue, [3H] oxytocin bound saturably to a high-affinity site.

    In plain wordsIn lab tests on rat heart tissue, oxytocin bound tightly to a specific site.

    Peptide
    Oxytocin
    Outcome
    Not applicableHigh-affinity [3H] oxytocin binding in rat left ventricle
    Study

    ratn: not reported in source

    Rat left ventricle micropunches
    Outcome group
    Receptor activity and mechanism · Cardiovascular
    Studied dose
    Dose not stated

    Measurements

    KD
    ≈ 1 nM
    high affinity site, rat left ventricle
    Bmax
    ≈ 1480 fmol/mg protein
    high affinity site, rat left ventricle

    Source sentences

    Summary
    Saturable, high affinity binding of [3H] oxytocin to rat left ventricle was observed, consisting of a high affinity site (affinity [KD] approximately 1 nM; receptor density [Bmax] approximately 1480 fmol/mg protein) and a higher capacity, lower affinity site (KD approximately 75 nM; Bmax 3730 fmol/mg protein).
    1 context sentence
    Summary · context
    A radioligand binding assay was used to characterize and quantify specific binding of [3H] oxytocin to standardized micropunches (thickness 400 microm; diameter 2 mm) obtained from rat left ventricle and human right atrium.
  2. 02LabEx vivo tissueActivity measurement

    In rat left ventricle tissue, [3H] oxytocin also bound to a higher-capacity, lower-affinity site.

    In plain wordsIn lab tests on rat heart tissue, oxytocin also bound to a second site with weaker grip but more capacity.

    Peptide
    Oxytocin
    Outcome
    Not applicableLower-affinity [3H] oxytocin binding in rat left ventricle
    Study

    ratn: not reported in source

    Rat left ventricle micropunches
    Outcome group
    Receptor activity and mechanism · Cardiovascular
    Studied dose
    Dose not stated

    Measurements

    KD
    ≈ 75 nM
    lower affinity site, rat left ventricle
    Bmax
    3730 fmol/mg protein
    lower affinity site, rat left ventricle

    Source sentences

    Summary
    Saturable, high affinity binding of [3H] oxytocin to rat left ventricle was observed, consisting of a high affinity site (affinity [KD] approximately 1 nM; receptor density [Bmax] approximately 1480 fmol/mg protein) and a higher capacity, lower affinity site (KD approximately 75 nM; Bmax 3730 fmol/mg protein).
    1 context sentence
    Summary · context
    A radioligand binding assay was used to characterize and quantify specific binding of [3H] oxytocin to standardized micropunches (thickness 400 microm; diameter 2 mm) obtained from rat left ventricle and human right atrium.
  3. 03LabEx vivo tissueActivity measurement

    In rat left ventricle tissue, [3H] oxytocin binding was displaced by oxytocin, vasopressin and an oxytocin agonist but not by the antagonist atosiban.

    In plain wordsIn lab tests on rat heart tissue, oxytocin binding was blocked by oxytocin, vasopressin and an agonist, but not by atosiban.

    Peptide
    Oxytocin
    Outcome
    Not applicableDisplacement of [3H] oxytocin binding
    Study

    ratn: not reported in source

    Rat left ventricle micropunches
    Outcome group
    Receptor activity and mechanism · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Binding was displaceable by oxytocin, vasopressin and the agonist [Thr4, Gly7] oxytocin but not by the antagonist atosiban.
    1 context sentence
    Summary · context
    A radioligand binding assay was used to characterize and quantify specific binding of [3H] oxytocin to standardized micropunches (thickness 400 microm; diameter 2 mm) obtained from rat left ventricle and human right atrium.
  4. 04LabEx vivo tissueActivity measurement

    In rat heart tissue, oxytocin binding was reduced in ovariectomized rats.

    In plain wordsIn rat heart tissue, oxytocin binding was lower in rats without ovaries.

    Peptide
    Oxytocin
    Outcome
    DecreaseCardiac oxytocin binding in ovariectomized rats
    Study

    ratn: not reported in source

    Rat left ventricle from ovariectomized rats
    Outcome group
    Receptor activity and mechanism · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Cardiac binding was reduced in ovariectomized (ie, estrogen-free) rats and increased in late gestation rats, when blood levels of ovarian steroids are maximal.
    1 context sentence
    Summary · context
    A radioligand binding assay was used to characterize and quantify specific binding of [3H] oxytocin to standardized micropunches (thickness 400 microm; diameter 2 mm) obtained from rat left ventricle and human right atrium.
  5. 05LabEx vivo tissueActivity measurement

    In rat heart tissue, oxytocin binding was increased in late gestation rats.

    In plain wordsIn rat heart tissue, oxytocin binding was higher in rats late in pregnancy.

    Peptide
    Oxytocin
    Outcome
    IncreaseCardiac oxytocin binding in late gestation rats
    Study

    ratn: not reported in source

    Rat left ventricle from late gestation rats
    Outcome group
    Receptor activity and mechanism · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    and increased in late gestation rats, when blood levels of ovarian steroids are maximal.
    1 context sentence
    Summary · context
    A radioligand binding assay was used to characterize and quantify specific binding of [3H] oxytocin to standardized micropunches (thickness 400 microm; diameter 2 mm) obtained from rat left ventricle and human right atrium.
  6. 06LabEx vivo tissueActivity measurement

    In fetal and newborn rat heart, cardiac oxytocin receptors were undetectable.

    In plain wordsIn lab tests on fetal and newborn rat hearts, no oxytocin binding sites could be found.

    Peptide
    Oxytocin
    Outcome
    Direction not reportedOxytocin binding in fetal and newborn rat heart
    Study

    ratn: not reported in source

    Fetal and newborn rat heart
    Outcome group
    Receptor activity and mechanism · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Cardiac oxytocin receptors were undetectable in fetal and newborn rat heart.
    1 context sentence
    Summary · context
    A radioligand binding assay was used to characterize and quantify specific binding of [3H] oxytocin to standardized micropunches (thickness 400 microm; diameter 2 mm) obtained from rat left ventricle and human right atrium.
  7. 07LabEx vivo tissueActivity measurement

    In human right atrial appendage samples, high concentrations of specific [3H] oxytocin binding were found.

    In plain wordsIn lab tests on human heart tissue, oxytocin bound at high levels to specific sites.

    Peptide
    Oxytocin
    Outcome
    Not applicableOxytocin binding in human right atrium
    Study

    humann: not reported in source

    Human right atrial appendage
    Outcome group
    Receptor activity and mechanism · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    High concentrations of specific [3H] oxytocin binding were also found in samples of human right atrial appendage.
    1 context sentence
    Summary · context
    A radioligand binding assay was used to characterize and quantify specific binding of [3H] oxytocin to standardized micropunches (thickness 400 microm; diameter 2 mm) obtained from rat left ventricle and human right atrium.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:51 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.